Comparison of PSA Response to Generic Versus Innovator (Zytiga) Formulations of Abiraterone in Metastatic CRPC: A Retrospective Analysis

Introduction Abiraterone acetate has been shown to enhance overall survival and radiographic progression-free survival (rPFS) in men with metastatic castration-resistant prostate cancer (mCRPC). Presently, multiple generic brands of abiraterone are accessible in India. Nevertheless,...

Full description

Saved in:
Bibliographic Details
Main Authors: Sharath Kumar, Amit Joshi, Apurva Takke, Diana Varghese, Shruti Pathak, Vanita Noronha, Kumar Prabhash, Vikram Gota
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2025-08-01
Series:Indian Journal of Medical and Paediatric Oncology
Subjects:
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1782235
Tags: Add Tag
No Tags, Be the first to tag this record!